Clinical Trials Browser

OTHER_GOV × Adenocarcinoma of Lung × Bevacizumab × Clear all

NCT05675033 2023-01-09

Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma

Phase 2 Unknown

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung